Darlene Noci

NUVL

Darlene Noci serves as officer: Chief Development Officer at Nuvalent, Inc. (NUVL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

52 trades

$26.59M

Net Position

Net Seller

$26.59M

Companies Traded

NUVL

Active Period

Feb 2022 – Jul 2026

52 total trades

Most Recent

Sell NUVL

Jul 6, 2026 · $2.84M

Darlene Noci's Insider Trading at Nuvalent, Inc. (NUVL)

Buys

0 · $0.00

Sells

2 · $368.0K

Total Shares Bought

Total Shares Sold

21,000

NUVL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 8, 2022	Sell	16,800	$17.61	$295.8K	0
Feb 16, 2022	Sell	4,200	$17.17	$72.1K	0

Showing 51–52 of 52

Related Insiders

Henry E. Pelish

officer: Chief Scientific Officer

NUVLSell · Jul 10, 2026

James Richard Porter

President and CEO

NUVLSell · Jul 8, 2026

Alexandra Balcom

officer: Chief Financial Officer

NUVLSell · Jul 6, 2026

Deborah Ann Miller

officer: Chief Legal Officer

NUVLSell · Jun 1, 2026

Christopher Durant Turner

officer: Chief Medical Officer

NUVLSell · Jan 7, 2026

James E Flynn

Director

NUVLSell · Nov 24, 2025

Matthew Shair

Director

NUVLSell · Nov 24, 2025

Explore More Insider Trading Data

NUVL Insider Trading Activity

View all insider trades at Nuvalent, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity